HROWHarrow HealthHROW info
$45.33info4.04%24h
Global rank5969
Market cap$1.59B
Change 7d-
YTD Performance306.18%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Harrow Health (HROW) Stock Overview

    Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products. The company offers ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounded medications. It also provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic medicines, including IOPIDINE and MOXEZA; MAXITROL eye drops; ILEVRO and NEVANAC, a non-steroidal and anti-inflammatory eye drop for pain and inflammation associated with cataract surgery; VIGAMOX, a fluoroquinolone antibiotic eye drop for the treatment of bacterial conjunctivitis; MAXIDEX, a steroid eye drop for steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe; TRIESENCE, a steroid injection for the treatment of ophthalmic diseases and for visualization during vitrectomy; and MAQ-100, a preservative-free triamcinolone acetonide ophthalmic injection drug candidate. The company was formerly known as Harrow Health, Inc. and changed its name to Harrow, Inc. in September 2023. Harrow, Inc. was founded in 1998 and is headquartered in Nashville, Tennessee.

    HROW Stock Information

    Symbol
    HROW
    Address
    102 Woodmont BoulevardNashville, TN 37205United States
    Founded
    -
    Trading hours
    -
    Website
    https://www.harrow.com
    Country
    🇺🇸 United States
    Phone Number
    615 733 4730

    Harrow Health (HROW) Price Chart

    -
    Value:-

    Harrow Health Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $45.33
    N/A
    Market Cap
    $1.59B
    N/A
    Shares Outstanding
    35.12M
    N/A
    Employees
    217.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org